Abstract. By fusing peripheral leukocytes from a patient with insulin-dependent diabetes with mouse myeloma cells, a heterohybridoma was isolated that, for over one year, has secreted a human monoclonal autoantibody, designated MOR-h 1 (multiple organ-reactive human 1). This antibody reacts with antigens in several endocrine organs including the pituitary, thyroid, stomach, and pancreas. By double immunofluorescence, MOR-hl was found to react specifically with growth hormone (GH)-containing cells in the anterior pituitary and, by enzyme-linked immunosorbent assay, MOR-h 1 was shown to react with both natural and biosynthetic GH. Absorption experiments revealed that GH could remove the capacity of MOR-hl to react not only with cells in the anterior pituitary, but also with cells in the thyroid, stomach, and pancreas. The demonstration with hyperimmune serum that these organs do not contain GH indicated that MOR-hl was reacting with a different molecule(s) in these organs. By passing extracts of pituitary, thyroid, and stomach through an MOR-hl affinity column and analyzing the eluted antigens by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a 35,000-mol wt polypeptide was isolated from each of these organs. In addition, a 21,500-mol wt polypeptide with an electrophoretic mobility identical to purified human GH was isolated from the pituitary, but not the other organs. It is concluded that MOR-h 1 reacts with a 35,000-mol wt polypeptide present in the pituitary, thyroid, and stomach and that this antibody also recognizes a determinant on GH.
Introduction
In many autoimmune diseases, sera from patients contain antibodies that react with antigens in multiple organs (1) (2) (3) . Because of the low titer of these antibodies and the polyclonality of sera, it has been difficult to determine whether different autoantibodies or the same autoantibody reacts with each of the organs. By hybridoma technology we isolated a number of monoclonal autoantibodies from mice (4, 5) . Many of these antibodies were found to recognize antigens in multiple organs (5) . Recently, we succeeded in preparing human monoclonal autoantibodies and found that many of them also were of the multiple organ-reactive (MOR)' type (6) . One of these, MORh1, reacts with cells in the pituitary, thyroid, stomach, and pancreas. The present investigation was initiated to isolate and compare the antigen(s) in the different organs with which MOR-h 1 reacts.
Methods
Monoclonal autoantibody. Peripheral blood lymphocytes from a patient with insulin-dependent diabetes mellitus were fused with mouse myeloma cells (Sp-l), and the hybridoma producing MOR-hl monoclonal antibody was isolated as previously reported (6) . This hybridoma has been secreting >20 jsg/ml of human monoclonal IgM(x) in RPMI-1640 medium supplemented with 15% fetal bovine serum for over 1 yr. Unconcentrated supernatant fluid from the hybridoma culture or supernatant fluid concentrated with 50% saturated ammonium sulfate was used throughout this study, except where indicated.
Fluorescence stainings ofhuman tissues. Paraffin-embedded human tissues fixed with Bouin's solution were used for indirect immunofluorescence (7). For An equal volume of Tris-saline containing 1% Nonidet P-40 (NP-40) was added, the homogenate was placed on ice, and then centrifuged at 100,000 g for I h to remove the particulate materials. The supernatant thus obtained was filtered through nitrocellulose membrane (0.2 um), sodium azide was added, and aliquots were stored at -20'C. About 10 g of frozen tissue was used to prepare each 100 ml of extract.
Purification of MOR-hi. MOR-hl was purified by affinity chromatography. Briefly, 1.0 g of freeze-dried CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ) powder was swollen and washed in 1 mM HC1 followed by washing with coupling buffer (0.1 M NaHCO3, 0.5 M NaCl, pH 8.3). Approximately 15 mg IgG from sheep anti-human IgM serum (Cappel Laboratories) was added and the mixture was subjected to end-over-end mixing for 2 h at room temperature. The remaining active groups on the Sepharose beads were blocked by incubation with 1 M ethanolamine (pH 8.0) for 2 h at room temperature and the mixture was poured into a column. The column was washed several times to remove unconjugated sheep IgG. Hybridoma supernatant fluid containing MOR-hl was then passed through the column at a rate of 15-20 ml/h. After washing with Trissaline, the bound MOR-hl was eluted with 0.1 M glycine-HCI (pH 2.5). The eluate was adjusted to pH 7.5, dialyzed against deionized water at 4VC, lyophilized, and stored at 4VC.
Purification ofautoantigens. Immuno-affinity columns were prepared by conjugating affinity purified MOR-hl to CNBr-activated Sepharose 4B as described above. Tissue extracts were passed through the column and after extensive washing, the absorbed antigens were eluted using 0.1 M glycine-HCI (pH 2.5). The eluate was adjusted to pH 7.5, dialyzed, lyophilized, redissolved in Tris-saline, and recycled through the affinity column. The recycled eluate was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to the procedure of Laemmli (9) .
Results
Identity of cells in the anterior pituitary with which MOR-hi reacts. We previously reported that MOR-hl reacts with cells in the anterior pituitary (6) . To identify the cell type involved, sections of the anterior pituitary were incubated with human MOR-hl and then with rabbit antisera to anterior pituitary hormones (i.e., anti-ACTH, -FSH, -LH, -PRL, -TSH, or -GH). The sections were subsequently stained with TRITC-conjugated anti-human IgM, which reacted with human MOR-hl, and with FITC-conjugated anti-rabbit IgG, which reacted with the rabbit anti-hormone antibodies (Fig. 1 Fig. 3 A and B , unabsorbed MOR-hl brilliantly stained cells in the anterior pituitary, whereas the absorbed MOR-hl failed to stain these cells. Natural GH and biosynthetic GH yielded similar results in both absorption experiments and ELISA.
Reactivity of MOR-hi with other organs. Since MOR-hl not only reacted with the anterior pituitary but also with cells in the thyroid, stomach, and pancreas, we wanted to see whether absorption with GH would reduce the capacity of MOR-hl to react with these organs. The data in Fig. 3 and Table I show that unabsorbed MOR-h 1 reacted with pituitary, thyroid, stomach, and pancreas, whereas absorbed MOR-h 1 did not react with these organs. To be certain that the absorption with GH was specific, MOR-hI was absorbed with insulin or BSA. Neither antigen significantly reduced the reactivity of MOR-hl with the pituitary, thyroid, stomach or pancreas (Table I ). In contrast, under identical conditions, insulin completely absorbed out the reactivity of a hyperimmune anti-insulin serum as monitored by the staining of pancreatic islet cells.
The demonstration that absorption of MOR-h 1 with GH eliminated its capacity to react with pituitary, thyroid, stomach, and pancreas raised the formal possibility that GH molecules might be present in these organs. To rule out this possibility, sections of these various organs were incubated with a known hyperimmune serum to GH. As seen in Table I , only cells in the anterior pituitary reacted with the hyperimmune serum to GH and absorption with GH eliminated this reactivity. This indicates that MOR-hl is not reacting with GH in the thyroid, stomach, and pancreas, but with a different molecule that may share a similar configuration or epitope with GH.
Isolation of MOR-hi reactive antigens. To determine the nature of the antigen(s) with which MOR-hl reacts, tissue extracts were passed through an MOR-hl affinity column, the bound molecules were eluted, concentrated, and analyzed by SDS-PAGE. As seen in Fig. 4 (lanes A and B) In the present experiments we showed that MOR-h 1 reacts with a 35,000-mol wt protein in the pituitary, thyroid, and stomach. Several proteins, including one of -35,000 mol wt, also have been isolated from the pancreas with an MOR-hl affinity column (Essani, K., and J. Satoh, unpublished observations). The demonstration of a 35,000 mol wt protein in three and perhaps four organs argues in favor of the first alternative that MOR-hl recognizes the same protein in different organs. However, the demonstration that MOR-h 1 reacts with a 21,500-mol wt protein (GH) isolated from the pituitary provides evidence in support of the second (and perhaps third) alternative that MOR-h 1 can react with different proteins. Thus, our experiments show that both possibilities can coexist. Moreover, the demonstration by immunofluores- IgG-producing cells (21, 22) . Polyreactive anti endow the immune system with an econom3
recognition.
